Anti-pancreatic cancer evaluation in vitro of transition metal–organic framework bearing imidazolyl benzoic acid and its interaction with DNA

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Journal of Molecular Liquids

• Publication date

  2025-11-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.molliq.2025.128509
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Progress in metal-organic frameworks (MOFs) as multifunctional material: Design, synthesis and anticorrosion performance techniques

  2025cited by this paper
• An insight into Synthetic, Structural and Medicinal perspective of imidazole analogs: A review.

  2025cited by this paper
• Novel anticancer agents, Pt complex with 1-pyrrolidineacetic acid ligand: Synthesis, biological activity, DNA interaction, molecular docking, and dynamic study

  2025cited by this paper
• Nano-Scale Anti-Cancer Drug Delivery by a Zn-Based Metal Organic Framework Carrier.

  2025cited by this paper
• Mitochondria-targeted iridium(III) complexes encapsulated in liposome induce cell death through ferroptosis and gasdermin-mediated pyroptosis.

  2024cited by this paper
• Nano-enabled regulation of DNA damage in tumor cells to enhance neoantigen-based pancreatic cancer immunotherapy.

  2024cited by this paper
• An Osteoimmunomodulatory Ca2+/Zn2+-Doped Scaffold Promotes M2 Macrophage Polarization via the Src-Mediated Chemoking Signaling Pathway to Enhance Osteoinduction

  2024cited by this paper
• Gemcitabine-Lipid Conjugate and ONC201 Combination Therapy Effectively Treats Orthotopic Pancreatic Tumor-Bearing Mice.

  2024cited by this paper
• E3 ubiquitin ligase UBR5 promotes gemcitabine resistance in pancreatic cancer by inducing O-GlcNAcylation-mediated EMT via destabilization of OGA

  2024cited by this paper
• Brain-specific targeted delivery of therapeutic agents using metal–organic framework-based nanomedicine

  2024cited by this paper
• Clinical immunotherapy in pancreatic cancer

  2024cited by this paper
• Apoptosis and cuproptosis Co-activated Copper-based metal-organic frameworks for cancer therapy

  2024cited by this paper
• Tumour‐associated neutrophils: Potential therapeutic targets in pancreatic cancer immunotherapy

  2024cited by this paper
• ZIF-8 Nanoparticle: A Valuable Tool for Improving Gene Delivery in Sperm-Mediated Gene Transfer

  2024cited by this paper
• Recent developments of nanomedicine delivery systems for the treatment of pancreatic cancer

  2023cited by this paper
• Ligand field tuning of d-orbital energies in metal-organic framework clusters

  2023cited by this paper
• New metal-organic framework coated sodium alginate for the delivery of curcumin as a sustainable drug delivery and cancer therapy system.

  2023cited by this paper
• Ultrahigh Enzyme Loading Metal-Organic Frameworks for Deep Tissue Pancreatic Cancer Photoimmunotherapy.

  2023cited by this paper
• Multifunctional nano MOF drug delivery platform in combination therapy.

  2023cited by this paper
• Sonodynamic Therapy of NRP2 Monoclonal Antibody‐Guided MOFs@COF Targeted Disruption of Mitochondrial and Endoplasmic Reticulum Homeostasis to Induce Autophagy‐Dependent Ferroptosis

  2023cited by this paper
• One-pot construction of gemcitabine loaded zeolitic imidazole framework for the treatment of lung cancer and its apoptosis induction

  2023cited by this paper
• Cancers make their own luck: theories of cancer origins

  2023cited by this paper
• Biomimetic targeting magnetite hollow nanostructures based on pH-responsive benzoic-imine bonds for antitumor activity

  2023cited by this paper
• Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine

  2022cited by this paper
• Membrane-camouflaged supramolecular nanoparticles for co-delivery of chemotherapeutic and molecular-targeted drugs with siRNA against patient-derived pancreatic carcinoma

  2022cited by this paper
• Polyhedral oligomeric silsesquioxane (POSS)-based hybrid nanocomposite for synergistic chemo-photothermal therapy against pancreatic cancer

  2022cited by this paper
• Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma

  2022cited by this paper
• Aperture Modulation of Isoreticular Metal Organic Frameworks for Targeted Antitumor Drug Delivery.

  2022cited by this paper
• Dinuclear doubly bridged phenoxido copper(II) complexes as efficient anticancer agents.

  2022cited by this paper
• Metal-Organic Frameworks-Based Antitumor Agents.

  2021cited by this paper
• Real‐world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinoma

  2021cited by this paper
• Liposome-based delivery of biological drugs

  2021cited by this paper
• Promotion of tumor progression induced by continuous low-dose administration of antineoplastic agent gemcitabine or gemcitabine combined with cisplatin.

  2021cited by this paper
• N-trimethyl chitosan coated nano-complexes enhance the oral bioavailability and chemotherapeutic effects of gemcitabine.

  2021cited by this paper
• Cr(V)-Cr(III) in-situ transition promotes ROS generation to achieve efficient cancer therapy.

  2021cited by this paper
• A systematic study of novel drug delivery mechanisms and treatment strategies for pancreatic cancer

  2021cited by this paper
• Metal-organic frameworks for advanced drug delivery

  2021cited by this paper
• Antıtumor actıvıty of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNS) ın vıtro and ın vıvo.

  2020cited by this paper
• Identifying Differing Intracellular Cargo Release Mechanisms by Monitoring In Vitro Drug Delivery from MOFs in Real Time

  2020cited by this paper
• Targeting Gemcitabine hydrochloride to tumor microenvironment through stimuli-responsive Nano-conjugate: Synthesis, characterization, and in vitro assessment

  2020cited by this paper
• Evaluating UiO-66 Metal-Organic Framework (MOF) Nanoparticles as Acid-Sensitive Carriers for Pulmonary Drug Delivery Applications.

  2020cited by this paper
• Design, synthesis and biological evaluation of naphthalenebenzimidizole platinum (II) complexes as potential antitumor agents.

  2020cited by this paper
• TAMing pancreatic cancer: combat with a double edged sword

  2019cited by this paper
• Photodynamic antitumor activity of Ru(ii) complexes of imidazo-phenanthroline conjugated hydroxybenzoic acid as tumor targeting photosensitizers.

  2019cited by this paper
• Enhanced Drug Delivery by Dissolution of Amorphous Drug Encapsulated in a Water Unstable MOF.

  2019cited by this paper
• Sustained co-delivery of gemcitabine and cis-platinum via biodegradable thermo-sensitive hydrogel for synergistic combination therapy of pancreatic cancer

  2019cited by this paper
• Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway

  2019cited by this paper
• FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

  2018cited by this paper
• Thymoquinone synergizes gemcitabine anti-breast cancer activity via modulating its apoptotic and autophagic activities

  2018cited by this paper

• No citing papers are available for this paper.